Mohammed Gbadamosi

MGbadamosiContact Information



B.Sc, University of Delaware – Newark, DE

Entry date into PTR PhD Program: Fall 2017
Curriculum Vitae



Research Interests

  • Pharmacogenomics
  • Personalized Medicine
  • AML
  • Cancer Genomics
  • Immunotherapy
  • Pediatric Leukemia


  • Graduate School Preeminence Award
  • McKnight Graduate Fellowship Affiliate
  • Board of Education Summer Fellowship

Professional Memberships

  • American Society for Clinical Pharmacology and Therapeutics (ASCPT) 
  • American Society of Hematology (ASH)
  • National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE)


  • Gbadamosi M, Meishinchi S, Lamba JK. Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia. Future Oncology. [In Review].